The Ohio State University James Comprehensive Cancer Center

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Melanoma2 trials
• Childhood cancers1 trial
• Chronic lymphocytic leukaemia1 trial

Phase

• Phase 1/21 trial
• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Terminated1 trial

Lead sponsor

• Regeneron Pharmaceuticals2 trials
• MingSight Pharmaceuticals, Inc1 trial

Running trials

• Active, not recruiting

  A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma

  NCT06190951· Phase 2· Regeneron Pharmaceuticals· Source

• Active, not recruiting

  A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

  NCT05608291· Phase 3· Regeneron Pharmaceuticals· Source

Closed trials

• Terminated

  A Study Of The Selective PKC-β Inhibitor MS- 553

  NCT03492125· Phase 1/2· MingSight Pharmaceuticals, Inc· Source